Treg modulation has been hypothesized as one of the mechanisms by which antitumor necrosis factor α (TNFα) agents exert their action in rheumatoid arthritis (RA) andinflammatory bowel disease (IBD). The gene discussed is TNF; the disease is irritable bowel syndrome.